46
Participants
Start Date
June 10, 2024
Primary Completion Date
April 30, 2025
Study Completion Date
November 30, 2025
Allocetra - Safety run-in phase
Intra-articular injection of Allocetra performed once on Day 1 of the study at different doses.
Placebo
Intra-articular injection of placebo solution containing all excipients except for the Allocetra cells.
Allocetra - Randomization phase
Intra-articular injection of selected dose of Allocetra based on the safety run-in, performed on Day 1 of the study.
RECRUITING
Kaplan Medical Center, Rehovot
Lead Sponsor
Kaplan Medical Center
OTHER